Unknown

Dataset Information

KCND2: A prognostic biomarker and regulator of immune function in gastric cancer.


ABSTRACT:

Background

Gastric cancer is a highly heterogeneous disease, which makes it challenging to develop effective targeted therapies. Although the potassium voltage-gated channel subfamily D (KCND) channels, particularly KCND2 (also known as Kv4.2), have found evidence of involvement in the occurrence and development of various cancers, there are still some limitations in our understanding of KCND2's roles in gastric cancer.

Methods

We analyzed the correlation between KCND2 expression and clinical features as well as immune infiltration using the Cancer Genome Atlas (TCGA) database. Functional assays of KCND2 were conducted using Cell counting Kit-8 (CCK8), clone formation assay and cell cycle analysis. Additionally, immunofluorescence, flow cytometry and quantitative real-time p

SUBMITTER: Zhou H 

PROVIDER: S-EPMC10469724 | biostudies-literature | 2023 Aug

REPOSITORIES: biostudies-literature